StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.52−0.27 (-3.47%)

Close on Nov 13, 2026Market cap $102.61MP/E –Yield 0.00%

Immunic profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for Immunic

Immunic has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Immunic figures

See a number that looks wrong?